California’s Office of Health Care Affordability has released a set of proposed regulations that significantly expand the state’s oversight of healthcare transactions.
The regulations, published on 15 May 2026, are designed to implement Assembly Bill 1415, which came into force on 1 January 2026.
The new rules represent a substantial broadening of the existing material change transaction notice process that OHCA already administers across the state.
Under the proposed framework, private equity groups will be required to give OHCA direct notice of any proposed material change transactions before they can proceed.
Hedge funds operating in the healthcare space will face the same direct notification obligations, marking a notable tightening of regulatory requirements for financial investors.
Management services organisations, commonly known as MSOs, are also captured within the scope of the proposed regulations, extending oversight into a widely used structure in healthcare.
Certain newly created entities would additionally be brought within the notification regime, closing potential gaps that may have previously allowed transactions to proceed without regulatory scrutiny.
The expansion reflects a growing trend among US states to subject healthcare transactions involving financial investors to greater transparency and government review before completion.
California has been among the most active states in developing frameworks that monitor how private capital interacts with healthcare providers and related organisations.
The OHCA was established with affordability and market oversight at its core, and the proposed regulations underline the agency’s expanding mandate within the state’s healthcare system.
Assembly Bill 1415 was passed amid broader concerns about the influence of private equity and hedge funds on healthcare delivery, costs, and access across California.
MSOs have attracted particular attention from regulators because they can be used to exert significant operational control over medical practices while technically remaining separate from clinical entities.
By requiring direct notice from these groups, OHCA will gain earlier visibility into transactions that could reshape healthcare markets before any changes take effect on the ground.
The proposed regulations are expected to generate significant engagement from healthcare investors, legal advisers, and provider groups as the formal comment process gets underway.